Every open market buy and sale of Clover Health Investments, Corp. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $8.8M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when CLOV insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an CLOV officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every CLOV insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Joseph Clay ThorntonCFO | Sale | 22,099 | $4.97 | $110K | 1,551,783 | Nov 17Form 4 |
| Oct 20, 2026 | Karen SoaresChief Legal Officer | Sale plan | 19,275 | $4.66 | $90K | 1,573,423 | Oct 20Form 4 |
| Oct 19, 2026 | Jamie L. ReynosoCEO, Medicare Advantage | Sale plan | 4,066 | $4.41 | $18K | 2,770,351 | Oct 20Form 4 |
| Oct 15, 2026 | Jamie L. ReynosoCEO, Medicare Advantage | Sale plan | 18,273 | $4.68 | $86K | 2,774,417 | Oct 19Form 4 |
| Oct 15, 2026 | Conrad WaiCEO, Counterpart Health | Sale plan | 23,627 | $4.68 | $111K | 1,042,072 | Oct 19Form 4 |
| Oct 15, 2026 | Joseph Clay ThorntonInterim CFO | Sale plan | 4,591 | $4.68 | $21K | 1,244,935 | Oct 19Form 4 |
| Oct 15, 2026 | Karen SoaresChief Legal Officer | Sale plan | 14,673 | $4.68 | $69K | 1,592,698 | Oct 19Form 4 |
| Oct 15, 2026 | Andrew ToyCEO | Sale plan | 62,176 | $4.68 | $291K | 9,078,334 | Oct 19Form 4 |
| Oct 7, 2026 | Jamie L. ReynosoCEO, Medicare Advantage | Sale plan | 2,006 | $4.63 | $9K | 2,792,690 | Oct 7Form 4 |
| Oct 5, 2026 | Jamie L. ReynosoCEO, Medicare Advantage | Sale plan | 8,750 | $4.42 | $39K | 2,794,696 | Oct 5Form 4 |
| Oct 1, 2026 | Andrew ToyCEO | Sale plan | 318,806 | $4.19 | $1.3M | 9,140,510 | Oct 2Form 4 |
| Sep 17, 2026 | Jamie L. ReynosoCEO, Medicare Advantage | Sale plan | 1,921 | $4.56 | $9K | 2,803,446 | Sep 18Form 4 |
| Sep 16, 2026 | Joseph Frank OldakowskiVP Of Finance And Controller | Sale plan | 3,170 | $4.64 | $15K | 275,897 | Sep 17Form 4 |
| Sep 15, 2026 | Conrad WaiCEO, Counterpart Health | Sale plan | 300,000 | $4.72 | $1.4M | 1,170,056 | Sep 16Form 4 |
| Sep 15, 2026 | Jamie L. ReynosoCEO, Medicare Advantage | Sale plan | 9,273 | $4.78 | $44K | 2,805,367 | Sep 15Form 4 |
CLOV insider trading FAQ
Are CLOV insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of CLOV on the open market in 0 trades, and 8 sold $8.8M in 42 trades, 87% of that under pre-arranged trading plans.
When did an CLOV insider last buy shares?
Anna U Loengard (Director) bought 26,500 shares for $69K on Aug 13, 2025, reported on Aug 14, 2025.
When did an CLOV insider last sell shares?
Joseph Clay Thornton (CFO) sold 22,099 shares for $110K on Nov 16, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
